<DOC>
	<DOCNO>NCT00778271</DOCNO>
	<brief_summary>The objective study compare single-dose relative bioavailability Ranbaxy Parke-Davis ( NeurontinÂ® ) 400 mg Gabapentin , follow administration 400 mg dose fasting condition</brief_summary>
	<brief_title>Bioequivalence Study Gabapentin 400 mg Capsules Under Fasting Conditions</brief_title>
	<detailed_description>This open-label , randomize , single-dose , 2-way crossover relative bioavailability study perform 24 healthy adult volunteer 2 alternate . A total 26 subject ( 22 male 4 female ) complete clinical phase study . In period , subject house least 10 hour dose 36-hour blood draw . Both period separate wash period 7 day A total 26 healthy adult volunteer ( 22 male 4 non-pregnant female ) enrol complete clinical phase study enrol complete clinical phase study</detailed_description>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Healthy adult male female volunteer , 1855 year age 2 . Weighing least 52 kg male 45 kg female within 15 % ideal weight ( Table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1983 ) 3 . Medically healthy subject clinically normal laboratory profile 4 . Females childbearing potential either sexually inactive ( abstinent ) 14 day prior study throughout study use one follow acceptable birth control method : surgically sterile ( bilateral tubal ligation , hysterectomy bilateral oophorectomy ) 6 month minimum ; IUD place least 3 month ; barrier method ( condom , diaphragm ) spermicide least 14 day prior start study throughout study ; surgical sterilization partner ( vasectomy 6 month minimum ) ; OR hormonal contraceptive least 3 month prior start study . Other birth control method may deem acceptable . Postmenopausal woman amenorrhea least 2 year eligible . 5 . Voluntarily consent participate study Subject candidate must enrol study meet follow criterion : 1 . History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease 2 . In addition , history presence : alcoholism drug abuse within past 2 year ; OR hypersensitivity idiosyncratic reaction antibiotic , especially penicillins , cephalosporins amoxicillin and/or clavulanic acid . 3 . Female subject pregnant lactate 4 . Subjects abnormal diet ( whatever reason ) 30 day prior first dose 5 . Subjects , completion study , would donate excess : 500 mL blood 14 day , 500 750 mL blood 14 day ( unless approve Principal Investigator ) , 1000 mL blood 90 day 1250 mL blood 120 day 1500 mL blood 180 day 2000 mL blood 270 day 2500 mL blood I year f ) Subjects participate another clinical trial within 28 day prior first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence gabapentin 400mg capsule fast condition</keyword>
</DOC>